MedPath
HSA Approval

XEPAGAN ELIXIR 10 mg/5 ml

SIN03294P

XEPAGAN ELIXIR 10 mg/5 ml

XEPAGAN ELIXIR 10 mg/5 ml

June 7, 1989

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R06AD02

promethazine

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

PROMETHAZINE HCl

10 mg/5 ml

Promethazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XEPAGAN ELIXIR 10 mg/5 ml - HSA Approval | MedPath